Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung- The Knockout Punch

被引：14
作者：
Tjong, M. C. [1 ]
Louie, A., V [1 ]
Singh, A. K. [2 ]
Videtic, G. [3 ]
Stephans, K. [3 ]
Plumridge, N. [4 ]
Harden, S. [4 ]
Slotman, B. J. [5 ]
Alongi, F. [6 ,7 ]
Guckenberger, M. [8 ]
Siva, S. [4 ]
机构：
[1] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Amsterdam Univ Med Ctr VUMC, Amsterdam, Netherlands
[6] IRCCS Sacro Cuore Don Calabria Hosp, Adv Radiat Oncol Dept, Negrar Verona, Italy
[7] Univ Brescia, Brescia, Italy
[8] Univ Zurich, Univ Hosp Zurich, Zurich, Switzerland
来源：
CLINICAL ONCOLOGY | 2022年 / 34卷 / 05期
关键词：
Ablative; lung; metastasis; NSCLC; radiotherapy; stereotactic; MEDICALLY INOPERABLE PATIENTS; RADIATION-THERAPY; CANCER; OLIGOMETASTASES; OUTCOMES; PHASE-2; TUMORS; SBRT; METASTASES; MANAGEMENT;
D O I：
10.1016/j.clon.2022.02.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, in comparison with the more widely adapted multi-fraction SABR regimens. A literature search using the Medline database through PubMed was carried out using the following key words: ('stereotactic' or 'sabr' or 'sbrt'), ('radiotherapy' or 'radiation therapy'), ('lung' or 'thorax' or 'thoracic' or 'chest'), ('cancer' or 'metasta-' or 'oligometasta-'), alongside: (i) ('single-fraction' or 'single-dose') to identify trials and cohort studies with single-fraction SABR to lung malignant tumours and (ii) ('fraction' or 'schedule') limiting the search to 'clinical trial' and 'randomized controlled trial' to ensure thorough capture of lung SABR trials comparing different fractionations. The review discusses the radiobiological, technical and organ at risk considerations of single-fraction SABR to the lung. (C) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：E183 / E194
页数：12
相关论文
共 50 条
[31]   Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report [J].
Yeo, Seung-Gu .
ONCOTARGETS AND THERAPY, 2017, 10 :3285-3288
[32]   Single centre experience with Stereotactic Ablative Body Radiotherapy for liver oligometastases [J].
Navero, Carmen Canadillas ;
Arregui, Inigo San Miguel ;
Boluda, Celia Nicolas ;
Hernandez, Gemma Alberca ;
Picon, Belen Cuesta ;
Lopez, Sara Medina ;
de Azagra, Jorge Ruiz Martinez ;
Repiso, Sofia Garcia .
RADIOTHERAPY AND ONCOLOGY, 2025, 206 :S1868-+
[33]   Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series [J].
Wegner, Rodney E. ;
Abel, Stephen ;
Hasan, Shaakir ;
Schumacher, Lana Y. ;
Colonias, Athanasios .
FRONTIERS IN ONCOLOGY, 2019, 9
[34]   The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus? [J].
Ong, Wee Loon ;
Loblaw, Andrew .
WORLD JOURNAL OF UROLOGY, 2023, 41 (12) :3485-3491
[35]   Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience [J].
Ricco, Anthony ;
Davis, Joanne ;
Rate, William ;
Yang, Jun ;
Perry, David ;
Pablo, John ;
D'Ambrosio, David ;
Sharma, Sanjeev ;
Sundararaman, Srinath ;
Kolker, James ;
Creach, Kimberly M. ;
Lanciano, Rachelle .
RADIATION ONCOLOGY, 2017, 12
[36]   Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer [J].
Niazi, Tamim ;
Elakshar, Sara ;
Stroian, Gabriela .
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) :351-358
[37]   Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients [J].
De Rose, F. ;
Cozzi, L. ;
Navarria, P. ;
Ascolese, A. M. ;
Clerici, E. ;
Infante, M. ;
Alloisio, M. ;
Testori, A. ;
Toschi, L. ;
Finocchiaro, G. ;
Santoro, A. ;
Scorsetti, M. .
CLINICAL ONCOLOGY, 2016, 28 (01) :13-20
[38]   The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma [J].
Ali, Muhammad ;
Mooi, Jennifer ;
Lawrentschuk, Nathan ;
Mckay, Rana R. ;
Hannan, Raquibul ;
Lo, Simon S. ;
Hall, William A. ;
Siva, Shankar .
EUROPEAN UROLOGY, 2022, 82 (06) :613-622
[39]   Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints [J].
Milano, Michael T. ;
Mihai, Alina ;
Kang, John ;
Singh, Deepinder P. ;
Verma, Vivek ;
Qiu, Haoming ;
Chen, Yuhchyau ;
Kong, Feng-Ming .
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (11) :959-969
[40]   Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy [J].
Tekatli, Hilal ;
Palacios, Miguel A. ;
Schneiders, Famke L. ;
Haasbeek, Cornelis J. A. ;
Slotman, Ben J. ;
Lagerwaard, Frank J. ;
Senan, Suresh .
RADIOTHERAPY AND ONCOLOGY, 2023, 187
12345